Identifying factors influencing alcohol relapse in liver transplant patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify risk and protective factors for alcohol relapse in patients with alcohol-related liver disease who have undergone liver transplantation. It consists of both retrospective and prospective components, collecting clinical data from patient medical records and conducting assessments during routine follow-up visits. The study will analyze patients' medical history, laboratory results, and psychosocial backgrounds to better understand the factors influencing relapse after transplantation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients who have signed the informed consent
* Candidates for liver transplantation due to liver disease with alcohol-related etiology (either mono- or multifactorial)
* For the retrospective part: patients who underwent OLT for ARLD during the time frame 2017-2022

Exclusion Criteria:

* Major psychopathologies and active psychoses

Where it's running

• IRCCS Azienda Ospedaliero-Universitaria di Bologna
  Bologna, Italy Recruiting

Study contacts

• Principal investigator: Maria Cristina Morelli, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Study coordinator: Maria Cristina Morelli, MD
• Email: mariacristina.morelli@aosp.bo.it
• Phone: 0512144248

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Endurance exercise to see if it lowers alcohol use in adults with AUD and ALD

  A 12-week home-based cycling program added to standard care is tested to see if it reduces alcohol use and cravings in adults with alcohol use disorder and alcohol-related liver disease.

  Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT07824089

• Peer support for liver transplant recipients with a history of alcohol use disorder

  This study tests whether having a peer support specialist helps liver transplant recipients with prior alcohol use disorder stay abstinent and stay engaged in care.

  Recruiting Johns Hopkins University · Baltimore, Maryland · NCT07397598

• HepQuant DuO blood test to track liver recovery after alcohol-related liver disease

  This tests whether the HepQuant DuO blood test can track liver recovery over one year in adults with alcohol-related liver disease or alcoholic hepatitis.

  Recruiting HepQuant, LLC · Redwood City, California · NCT07060547

• Using fecal microbiota transplantation to prevent infections after liver transplantation

  This study is testing if a special treatment using healthy stool can help prevent infections in people getting a liver transplant.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna · NCT06782880

• Mobile app for alcohol cessation in liver disease patients

  This study is testing whether a smartphone app can help people with alcohol-related liver disease stop drinking more effectively than just regular care alone.

  Recruiting at 3 sites University of Wisconsin, Madison · Lansing, Michigan and 2 other locations · NCT06305624

• Helping people with alcohol-related liver disease find and start alcohol treatment

  This trial tests whether a tailored web app plus a follow-up coaching bundle can help people with alcohol-related liver disease start and stay in alcohol-use treatment.

  Recruiting Henry Ford Health System · Detroit, Michigan · NCT06269510

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.